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Neck Cancer Patients
Joke M. Kwakman, DMD; Hans-Peter M. Freihofer, MD, DMD, PhD; Marinus A. J. van Waas, DMD, PhD
After cancer treatment in the head and neck 
area, mastication and speech are often affected. 
Some of the problems encountered can be solved by 
adequate dental rehabilitation. However, dental re­
habilitation is often compromised for various rea­
sons. The change in anatomy due to surgery often re­
sults in lack of denture-bearing mucosa. The effects 
of radiotherapy on the salivary glands and the mu­
cosa result in dry oral tissue and diminished reten­
tion of removable dentures. Osseointegrated oral im­
plants can help to solve these problems. Although 
implant treatment for patients with cancer of the 
head and neck is covered by the Dutch national 
health insurance, and there is therefore no financial 
obstacle, implants have not, so far, been widely used 
with these patients. In order to establish the possi­
ble reasons for this, an analysis was performed. Ret­
rospective data on 95 consecutive patients were col­
lected from records. The indication for the use of 
oral osseointegrated implants was reviewed. Analy­
sis of the data showed that 45% did not need specific 
prosthetic rehabilitation. An indication for the use 
of osseointegrated implants was found in 25% of the 
patients. For various reasons, only 3% actually re­
ceived implants. In striving to completely rehabili­
tate a cancer patient, the possible use of osseointe­
grated oral implants should be evaluated before the 
initial oncological treatment begins. The insertion of 
implants during the initial surgical procedure 
should be considered more often, with a view to re­
ducing the number of surgical procedures.
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INTRODUCTION
Osseointegrated oral implants are widely used 
and accepted for prosthetic treatment of edentulous 
and partial edentulous patients. A good restoration 
of esthetics and function is possible when using 
fixed bridges or overdentures, and the long-term re­
sults are good.1-3 The application of osseointegrated 
oral implants after treatment of malignancies of the 
head and neck would, therefore, also appear to be 
plausible.
For various reasons, the prosthetic rehabilita­
tion of these patients is compromised. In dentate pa­
tients, loss of teeth occurs because of the ablative 
surgery and/or due to radiotherapy. In both dentate 
and edentulous patients, the prosthetic manage­
ment is complicated by the changes in anatomy due 
to surgery When a pedicled musculocutaneous graft 
or a free vascularized graft is used for surgical re­
construction, denture function will be impaired due 
to the frequent excess of soft tissue and lack of den­
ture-bearing mucosa. The effects of irradiation on 
the mucosa, salivary glands, and saliva itself have 
an additional negative influence on the function of 
the dentures.
In the literature, case reports have been pub­
lished on the successful oral rehabilitation with os­
seointegrated oral implants.4-7
Esser and Montag8 published a study relating 
to a group of 23 patients treated with osseointe­
grated oral implants after tumor treatment of the 
lower third of the face. Some of the patients had had 
radiotherapy. The maximum follow-up of this group 
of patients was 30 months. The implantation proce­
dure was carried out 1 year after the irradiation. 
Two patients lost their implants due to lack of os- 
seointegration. One patient lost his implants be­
cause of treatment of a local recurrence, Riediger9 
reported the implantation in a free vascularized
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crista iliaca graft in nine patients. All implants were 
functional after a maximum follow-up of 30 months. 
Albrektsson et al.3 reported on 31 implants in irra­
diated mandibles and maxillae. No implants were 
lost after a follow-up of 1 to 5 years. Taylor and Wor­
thington10 published their results relating to four 
patients treated with oral implants after radiother­
apy and surgical treatm ent of a tumor in the head 
and neck. Three patients were treated with hyper­
baric oxygen prior to implantation. The follow-up for 
the implants was 2 to 7 years. None of the implants 
were lost. Neukam et al.11 inserted 110 oral im­
plants in 21 tumor patients and 26 extraoral im­
plants in nine patients. Twelve implants placed in- 
traorally were lost.
Urken et al.12 reported on a group of 10 patients 
reconstructed with an iliac crest free flap and os- 
seointegrated implants, of which four had received 
radiotherapy Evaluation showed that these patients 
had a stable and retentive prosthesis and a better 
chewing ability than a nonreconstructed group.
It would therefore appear th a t osseointegrated 
oral implants can be successfully used in these pa­
tients. No serious adverse effects when osseointe- 
gration failed, such as osteoradionecrosis or loss of a 
bone graft, have been published.
We have noticed, however, tha t although the 
treatment is feasible, successful, and available to all 
patients, only a few patients are actually treated 
with oral implants in our clinic. An analysis was 
performed to review the indications for implant 
placement and the specific reasons why only a few 
patients were treated with implants.
MATERIALS AND METHODS
A review was carried out, using patient records, of all 
the patients who presented themselves between January 
1989 and December 1990 to the Department of Oral and 
Maxillofacial Surgery at the University Hospital Nijmegen 
with tumors of the head and neck. The following data were 
obtained: tumor diagnosis and TNM classification,13 loca­
tion of the tumor, dental status before treatment, the spe­
cific treatment of the tumor, and the prosthetic rehabilita­
tion. The indications for placement of oral implants were 
retrospectively reviewed. During the 2 years, 95 patients 
presented themselves (33 women and 62 men); their ages 
varied from 30 to 91, with a mean of 62 years.
TABLE II. 
Treatment of the Tumor (n = 95).
Mode of therapy Number
Surgery 35
Surgery followed by radiotherapy 44
Radiotherapy followed by surgery 2
Radiotherapy and/or chemotherapy 14
RESULTS
Diagnosis
Of the 95 patients, six were diagnosed as hav­
ing a metastasis from another site.
Of the remaining patients, 59 were classified as 
having a Ti or T2 tumor and 30 as having a T3 or T4. 
By far the most tumors were squamous cell carcino­
mata. The tumors were most frequently localized in 
the tongue and the floor of the mouth (Table I).
Tumor Treatment
Eighty-one patients were treated surgically 
with a local resection (Table II), and in 61 cases this 
was combined with a neck dissection. Forty-six also 
received radiotherapy, with an irradiation dose 
ranging from 64 to 70 Gy.
Fourteen patients were treated by radiotherapy 
and/or chemotherapy only.
In Table III, the type of surgery is specified. In 
most of the patients, only soft tissues were resected 
(58). In 23 patients, a resection of bone had to be 
performed as well.
In all the patients who underwent a resection of 
the mandible with loss of continuity (n = 7), the de­
fect was closed with a pectoralis major musculo-cu- 
taneous flap. In six patients, this was combined with 
an AO reconstruction plate.
Dental Status
Before treatment, 67 patients were completely 
edentulous. The remaining 28 patients were at least 
partially dentate. The resections compared to the
TABLE I. 
Location of the Tumor (n ii CO •
TABLE III.
Type of Surgery (n = 81).
Location Number Surgical Treatment Number
Tongue 25 Partial resecton of the maxilla 8
Floor of the mouth 31 Partial resection of the mandible with loss of continuity 7
Retromolar pad, pharynx 12 Partial resection of the lingual cortex of the mandible 6
Maxilla 12 Partial resection of the mandibular alveolar process 2
Remainder 15 Soft tissue resection only 58
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Fig. 1. Intraoral view of patient with soft tissue reconstruction insuffi­
cient for dentai rehabilitation without correction of soft tissue and in­
sertion of dental implants.
dental status are shown in Table IV. As a conse­
quence of the treatment, teeth were extracted in 14 
patients. Seven patients lost teeth at the site of the 
resection of the tumor, and seven others lost teeth 
because the teeth were seen as a complicating factor 
in relation to radiotherapy.
As a result of these extractions, six patients be­
came edentulous.
Prosthetic Treatment
Of the 28 patients with their own (partial) den­
tition, 12 did not need any special prosthetic treat­
ment postoperatively. Eleven of them had an ade­
quately functioning partial denture, sometimes 
requiring minor adjustments. One patient died 
shortly after surgery. Four patients had no remov­
able dentures at the time of the evaluation, al­
though there was a strong indication for prosthetic 
treatment (two patients had become completely
Fig. 2. Preoperative view of localization of leukoplakia and squamous 
cell carcinoma in floor of the mouth.
Fig. 3. Intraoral situation after resection of tumor including part of the 
Inferior alveolar process with loss of teeth and reconstruction with 
osseointegrated oral implants and fixed bridge.
edentulous). However, three of them refused den­
tures, and the fourth patient had a poor prognosis.
Of the 67 edentulous patients, 21 received new 
dentures that functioned well. Eight patients re­
fused dentures. Twenty-six patients died before the 
time of the evaluation. The 12 remaining patients 
either have no dentures or dentures which function 
poorly, and could probably benefit from oral im­
plants. Five of these patients have had a bone resec­
tion of some sort. Of these 12 remaining patients, 
four refused implantation. One patient has devel­
oped an osteoradionecrosis of the mandible, which is 
a contraindication for inserting implants. One pa­
tient recently had a local recurrence. Two patients 
developed Alzheimer’s disease. Another patient had 
a mandibular height of 5 mm, too low for insertion 
of implants. At a later stage, an alveolar ridge aug­
mentation combined with implants might be appro­
priate. Therefore, only three patients were finally 
treated with implants, a total of 3% of the entire 
group (Table V).
DISCUSSION AND CONCLUSIONS
The patient is seen by the prosthodontist after 
the wound has healed or postoperative radiotherapy 
has been completed, Twelve patients did not need 
any prosthetic treatment. Thirty-two patients were 
treated by making conventional removable den-
TABLE IV.
Dental Status and Surgical Treatment.
Surgical Treatment
Dentate 
(n = 24)
Edentulous 
(n = 57)
Total
(n = 81)
Resection of the maxilla 4 4 8
Resection of the mandible 5 10 15
Soft tissue only 15 43 58
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Table V.
Results (n = 95).
No prosthetic treatment necessary 12
Adequate conventional prosthetic treatment 32
Deceased or bad prognosis 28
Refused prosthetic treatment and/or implants 15
Local or general contraindications 5
Implant treatment 3
tures. Therefore, 45% did not need specific pros­
thetic treatment.
Oral implants are considered if complete den­
tures are considered inopportune or dentures do not 
function well. At this stage, 15 patients refused fur­
ther treatment. The adverse reactions of these 15 
patients to prosthetic treatm ent and implants were 
partly due to the fact that patients did not want to 
undergo further treatment, surgical or prosthetic, 
which was not essential for their survival at that 
time. Some patients stated that they had never had 
good dentures and therefore had no need for them 
now. Another reason for the low number of patients 
treated with implants could be that, during the ini­
tial discussion about their tumor treatment, no 
mention was made of possible reconstruction with 
oral implants. Moreover, the patient was sometimes 
told that he/she might in fact never again have den­
tures that functioned well. The patients’ expecta­
tions therefore remained low. Because implant 
treatment and prosthetic treatm ent in these pa­
tients is covered by national health insurance, the 
explanation for this situation cannot be financial.
Although 24 patients (25%) could theoretically 
benefit from oral implants when we looked at their 
oral and dental conditions, six (7%) had to be ex­
cluded due to local and general contraindications. 
Fifteen (15%) refused treatment, but might still be 
candidates at a later stage. Just three (3%) of our se­
ries actually received implants. Taking into consid­
eration all the factors, we do not expect there to be a 
significant increase in the demand for implants as a 
second procedure. When striving to rehabilitate the
cancer p a tien t a t a  h igh prosthetic  s tan d ard , the in­
dication for oral im plants m u st be considered before 
the  in itial tre a tm e n t of th e  malignancy. The inser­
tion of oral im plants, in com bination w ith  th e  initial 
surgical procedure, should probably be considered 
m ore often.
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